Figure 3 | Scientific Reports

Figure 3

From: FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab

Figure 3

Probability estimates of the prognosis of study patients with metastatic urothelial carcinoma who were treated with pembrolizumab and stratified by the FAN score. Probability estimates of progression-free survival (PFS) (a) and cancer-specific survival (CSS) (b) for the 165 patients stratified by the FAN score in the discovery cohort. Probability estimates of PFS (c) and CSS (d) for the 103 patients stratified by the FAN score in the validation cohort.

Back to article page